These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38740304)

  • 1. Risk factors for in-hospital acquisition of carbapenem-resistant Enterobacterales in patients with severe burns.
    Han SB; Jeon K; Kim M; Park J; Yoon J; Cho YS; Hur J; Chun W; Kym D
    J Hosp Infect; 2024 Jul; 149():165-171. PubMed ID: 38740304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study.
    Zhou H; Buetti N; Pérez-Galera S; Bravo-Ferrer J; Gutiérrez-Gutiérrez B; Paniagua-García M; Feifel J; Sauser J; Kostyanev T; Canton R; Tan LK; Basoulis D; Pintado V; Roilides E; Dragovac G; Torre-Cisneros J; Mediç D; Akova M; Goossens H; Bonten M; Harbarth S; Rodriguez-Baño J; De Kraker MEA;
    J Antimicrob Chemother; 2024 Sep; 79(9):2132-2141. PubMed ID: 38988305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Insights Into the Mechanism of Carbapenem Resistance Dissemination in Enterobacterales From a Tertiary Public Heath Setting in South Asia.
    Farzana R; Jones LS; Rahman MA; Sands K; van Tonder AJ; Portal E; Criollo JM; Parkhill J; Guest MF; Watkins WJ; Pervin M; Boostrom I; Hassan B; Mathias J; Kalam MA; Walsh TR
    Clin Infect Dis; 2023 Jan; 76(1):119-133. PubMed ID: 35412593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
    Hassoun-Kheir N; Hussein K; Karram M; Saffuri M; Badaan S; Peleg S; de Kraker MEA; Aboelhega W; Warman S; Alon T; Eluk O; Geffen Y; Paul M
    Clin Microbiol Infect; 2023 May; 29(5):629-634. PubMed ID: 36641053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.
    Moghnieh R; Abdallah D; Jadayel M; Zorkot W; El Masri H; Dib MJ; Omar T; Sinno L; Lakkis R; Jisr T
    Sci Rep; 2021 Jul; 11(1):14757. PubMed ID: 34285312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors of carbapenem-resistant
    Aleidan FAS; Alkhelaifi H; Alsenaid A; Alromaizan H; Alsalham F; Almutairi A; Alsulaiman K; Abdel Gadir AG
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):393-398. PubMed ID: 32930620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
    Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
    Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics of carbapenem-resistant
    Sun Y; Zheng H; Zhang JL; Yu LX; Wang B; Gao W; Cai JZ; Liu YH
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):640-645. PubMed ID: 32842384
    [No Abstract]   [Full Text] [Related]  

  • 10. The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
    Asai N; Sakanashi D; Suematsu H; Kato H; Hagihara M; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jul; 24(7):505-509. PubMed ID: 29548627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
    Wang Q; Zhang Y; Yao X; Xian H; Liu Y; Li H; Chen H; Wang X; Wang R; Zhao C; Cao B; Wang H
    Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1679-89. PubMed ID: 27401905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Risk Factors of Carbapenem-resistant
    Kang JS; Yi J; Ko MK; Lee SO; Lee JE; Kim KH
    J Korean Med Sci; 2019 May; 34(18):e140. PubMed ID: 31074254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of rectal carbapenem resistant Enterobacterales carriage among patients attending healthcare facilities in Ibadan, Nigeria: a descriptive study.
    Adekanmbi O; Popoola O; Fowotade A; Idowu O; Ogunbosi B; Lakoh S; Adebiyi I; Ayandipo O; Iyun AO
    BMC Infect Dis; 2024 Jul; 24(1):726. PubMed ID: 39048999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular surveillance of carbapenem-resistant Enterobacterales in two nearby tertiary hospitals to identify regional spread of high-risk clones in Germany, 2019-2020.
    Boutin S; Welker S; Gerigk M; Miethke T; Heeg K; Nurjadi D
    J Hosp Infect; 2024 Jul; 149():126-134. PubMed ID: 38723905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
    Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M
    Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors and clinical prognosis analysis of carbapenem-resistant
    Zhang AR; Wang Q; Zhou CE; Zhang JG; Wang XJ; Zhao JK; Lu BH; Yang CX; Gu L; Ma LY; Su JR; Cao B; Wang H
    Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(21):1572-1582. PubMed ID: 34098684
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency of and risk factors for carbapenem-resistant
    Barber KE; Wagner JL; Larry RC; Stover KR
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33263511
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
    Lee GC; Lawson KA; Burgess DS
    Ann Pharmacother; 2013 Sep; 47(9):1115-21. PubMed ID: 24259725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.